269 related articles for article (PubMed ID: 25266665)
1. Trefoil factor 3 promotes metastatic seeding and predicts poor survival outcome of patients with mammary carcinoma.
Pandey V; Wu ZS; Zhang M; Li R; Zhang J; Zhu T; Lobie PE
Breast Cancer Res; 2014 Sep; 16(5):429. PubMed ID: 25266665
[TBL] [Abstract][Full Text] [Related]
2. ARTEMIN synergizes with TWIST1 to promote metastasis and poor survival outcome in patients with ER negative mammary carcinoma.
Banerjee A; Wu ZS; Qian P; Kang J; Pandey V; Liu DX; Zhu T; Lobie PE
Breast Cancer Res; 2011; 13(6):R112. PubMed ID: 22060274
[TBL] [Abstract][Full Text] [Related]
3. Trefoil Factor-3 (TFF3) Stimulates De Novo Angiogenesis in Mammary Carcinoma both Directly and Indirectly via IL-8/CXCR2.
Lau WH; Pandey V; Kong X; Wang XN; Wu Z; Zhu T; Lobie PE
PLoS One; 2015; 10(11):e0141947. PubMed ID: 26559818
[TBL] [Abstract][Full Text] [Related]
4. Trefoil factor 3 is oncogenic and mediates anti-estrogen resistance in human mammary carcinoma.
Kannan N; Kang J; Kong X; Tang J; Perry JK; Mohankumar KM; Miller LD; Liu ET; Mertani HC; Zhu T; Grandison PM; Liu DX; Lobie PE
Neoplasia; 2010 Dec; 12(12):1041-53. PubMed ID: 21170268
[TBL] [Abstract][Full Text] [Related]
5. Expression of two non-mutated genetic elements is sufficient to stimulate oncogenic transformation of human mammary epithelial cells.
Pandey V; Zhang M; You M; Zhang W; Chen R; Zhang W; Ma L; Wu ZS; Zhu T; Xu XQ; Lobie PE
Cell Death Dis; 2018 Nov; 9(12):1147. PubMed ID: 30451834
[TBL] [Abstract][Full Text] [Related]
6. Gene expression alterations associated with outcome in aromatase inhibitor-treated ER+ early-stage breast cancer patients.
Thomsen KG; Lyng MB; Elias D; Vever H; Knoop AS; Lykkesfeldt AE; Lænkholm AV; Ditzel HJ
Breast Cancer Res Treat; 2015 Dec; 154(3):483-94. PubMed ID: 26585578
[TBL] [Abstract][Full Text] [Related]
7. [Activation and prognostic significance of AKT, NF-kappaB and STAT3 in breast cancer with lymph node metastasis and estrogen receptor expression].
Liu C; Zhou S; Ke CS; Li NP; Wu RL
Ai Zheng; 2007 Sep; 26(9):929-36. PubMed ID: 17927847
[TBL] [Abstract][Full Text] [Related]
8. Small molecule inhibition of TFF3 overcomes tamoxifen resistance and enhances taxane efficacy in ER+ mammary carcinoma.
Guo H; Tan YQ; Huang X; Zhang S; Basappa B; Zhu T; Pandey V; Lobie PE
Cancer Lett; 2023 Nov; 579():216443. PubMed ID: 37858772
[TBL] [Abstract][Full Text] [Related]
9. Expression of trefoil factors and TWIST1 in colorectal cancer and their correlation with metastatic potential and prognosis.
Yusup A; Huji B; Fang C; Wang F; Dadihan T; Wang HJ; Upur H
World J Gastroenterol; 2017 Jan; 23(1):110-120. PubMed ID: 28104986
[TBL] [Abstract][Full Text] [Related]
10. A novel role for ezrin in breast cancer angio/lymphangiogenesis.
Ghaffari A; Hoskin V; Szeto A; Hum M; Liaghati N; Nakatsu K; LeBrun D; Madarnas Y; Sengupta S; Elliott BE
Breast Cancer Res; 2014 Sep; 16(5):438. PubMed ID: 25231728
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological Inhibition of TFF3 Enhances Sensitivity of CMS4 Colorectal Carcinoma to 5-Fluorouracil through Inhibition of p44/42 MAPK.
Chen RM; Chiou YS; Chong QY; Poh HM; Tan TZ; Zhang MY; Ma L; Zhu T; Pandey V; Basappa ; Kumar AP; Lobie PE
Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31835445
[TBL] [Abstract][Full Text] [Related]
12. Monomerization of Homodimeric Trefoil Factor 3 (TFF3) by an Aminonitrile Compound Inhibits TFF3-Dependent Cancer Cell Survival.
Pandey V; Zhang X; Poh HM; Wang B; Dukanya D; Ma L; Yin Z; Bender A; Periyasamy G; Zhu T; Rangappa KS; Basappa B; Lobie PE
ACS Pharmacol Transl Sci; 2022 Sep; 5(9):761-773. PubMed ID: 36110371
[TBL] [Abstract][Full Text] [Related]
13. C-X-C motif chemokine 12/C-X-C chemokine receptor type 7 signaling regulates breast cancer growth and metastasis by modulating the tumor microenvironment.
Wani N; Nasser MW; Ahirwar DK; Zhao H; Miao Z; Shilo K; Ganju RK
Breast Cancer Res; 2014 May; 16(3):R54. PubMed ID: 24886617
[TBL] [Abstract][Full Text] [Related]
14. Trefoil factors peptide-3 is associated with residual invasive breast carcinoma following neoadjuvant chemotherapy.
Al-Salam S; Sudhadevi M; Awwad A; Al Bashir M
BMC Cancer; 2019 Feb; 19(1):135. PubMed ID: 30744593
[TBL] [Abstract][Full Text] [Related]
15. Trefoil factor 3 mediation of oncogenicity and chemoresistance in hepatocellular carcinoma is AKT-BCL-2 dependent.
You ML; Chen YJ; Chong QY; Wu MM; Pandey V; Chen RM; Liu L; Ma L; Wu ZS; Zhu T; Lobie PE
Oncotarget; 2017 Jun; 8(24):39323-39344. PubMed ID: 28445151
[TBL] [Abstract][Full Text] [Related]
16. Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer.
Zhang H; Stephens LC; Kumar R
Clin Cancer Res; 2006 Mar; 12(5):1479-86. PubMed ID: 16533771
[TBL] [Abstract][Full Text] [Related]
17. ARTEMIN promotes de novo angiogenesis in ER negative mammary carcinoma through activation of TWIST1-VEGF-A signalling.
Banerjee A; Wu ZS; Qian PX; Kang J; Liu DX; Zhu T; Lobie PE
PLoS One; 2012; 7(11):e50098. PubMed ID: 23185544
[TBL] [Abstract][Full Text] [Related]
18. Trefoil factor family 3 (TFF3) expression and its interaction with estrogen receptor (ER) in endometrial adenocarcinoma.
Mhawech-Fauceglia P; Wang D; Samrao D; Liu S; DuPont NC; Pejovic T
Gynecol Oncol; 2013 Jul; 130(1):174-80. PubMed ID: 23578537
[TBL] [Abstract][Full Text] [Related]
19. TFF3 is a normal breast epithelial protein and is associated with differentiated phenotype in early breast cancer but predisposes to invasion and metastasis in advanced disease.
Ahmed ARH; Griffiths AB; Tilby MT; Westley BR; May FEB
Am J Pathol; 2012 Mar; 180(3):904-916. PubMed ID: 22341453
[TBL] [Abstract][Full Text] [Related]
20. LAPTM4B Predicts Axillary Lymph Node Metastasis in Breast Cancer and Promotes Breast Cancer Cell Aggressiveness in Vitro.
Xiao M; Yang S; Meng F; Qin Y; Yang Y; Jia S; Cai X; Li C; Huang Y; Ning X
Cell Physiol Biochem; 2017; 41(3):1072-1082. PubMed ID: 28245476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]